MindBio Therapeutics Statistics
Total Valuation
CSE:MBIO has a market cap or net worth of CAD 655,476. The enterprise value is 2.54 million.
Important Dates
The last earnings date was Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:MBIO has 7.28 million shares outstanding. The number of shares has increased by 691.67% in one year.
| Current Share Class | 7.28M |
| Shares Outstanding | 7.28M |
| Shares Change (YoY) | +691.67% |
| Shares Change (QoQ) | -9.39% |
| Owned by Insiders (%) | 2.10% |
| Owned by Institutions (%) | n/a |
| Float | 7.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.25
| Current Ratio | 0.25 |
| Quick Ratio | 0.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,213.07% |
| Return on Invested Capital (ROIC) | -1,843.29% |
| Return on Capital Employed (ROCE) | 196.29% |
| Weighted Average Cost of Capital (WACC) | 7.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.80% in the last 52 weeks. The beta is -0.75, so CSE:MBIO's price volatility has been lower than the market average.
| Beta (5Y) | -0.75 |
| 52-Week Price Change | -92.80% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 43.40 |
| Average Volume (20 Days) | 23,947 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.62M |
| Pretax Income | -4.47M |
| Net Income | -4.46M |
| EBITDA | n/a |
| EBIT | -3.62M |
| Earnings Per Share (EPS) | -1.10 |
Full Income Statement Balance Sheet
The company has 336,655 in cash and 2.29 million in debt, with a net cash position of -1.95 million or -0.27 per share.
| Cash & Cash Equivalents | 336,655 |
| Total Debt | 2.29M |
| Net Cash | -1.95M |
| Net Cash Per Share | -0.27 |
| Equity (Book Value) | -1.85M |
| Book Value Per Share | -0.24 |
| Working Capital | -1.85M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -2.17M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:MBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -691.67% |
| Shareholder Yield | -691.67% |
| Earnings Yield | -1,220.72% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on November 6, 2025. It was a reverse split with a ratio of 0.0025.
| Last Split Date | Nov 6, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |